Cargando…

Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy

Background: Immunogenic cell death (ICD) could activate innate and adaptive immune response. In this work, we aimed to develop an ICD-related signature in uveal melanoma (UVM) patients and facilitate assessment of their prognosis and immunotherapy. Methods: A set of machine learning methods, includi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaoyan, Kang, Jing, Yue, Jing, Xu, Dawei, Liao, Chunhua, Zhang, Huina, Zhao, Jin, Liu, Qiongwen, Jiao, Jinke, Wang, Lin, Li, Guoyin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449274/ https://www.ncbi.nlm.nih.gov/pubmed/37142279 http://dx.doi.org/10.18632/aging.204680

Ejemplares similares

Machine learning-based construction of immunogenic cell death-related score for improving prognosis and response to immunotherapy in melanoma
por: Li, Guoyin, et al.
Publicado: (2023)

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
por: Hu, Yuanyuan, et al.
Publicado: (2022)

Uveal melanoma: Estimating prognosis
por: Kaliki, Swathi, et al.
Publicado: (2015)

Immunotherapies for the Treatment of Uveal Melanoma—History and Future
por: Schank, Timo E., et al.
Publicado: (2019)

Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
por: Castet, Florian, et al.
Publicado: (2019)

Recent Advances and Challenges in Uveal Melanoma Immunotherapy
por: Fu, Yihang, et al.
Publicado: (2022)

An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
por: Liao, Xinghe, et al.
Publicado: (2022)

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
por: Mignard, Claire, et al.
Publicado: (2018)

Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
por: Rossi, Ernesto, et al.
Publicado: (2019)

Integrated single-cell and transcriptome sequencing analyses develops a metastasis-based risk score system for prognosis and immunotherapy response in uveal melanoma
por: Meng, Shuting, et al.
Publicado: (2023)

Expression of EZH2 in uveal melanomas patients and associations with prognosis
por: Cheng, Ying, et al.
Publicado: (2017)

DNA Methylation and Uveal Melanoma
por: Yang, Zhi-Kun, et al.
Publicado: (2018)

How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma
por: Marseglia, Mariarosaria, et al.
Publicado: (2021)

A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy
por: Fadel, Celine A, et al.
Publicado: (2022)

GOLM1 is related to the inflammatory/immune nature of uveal melanoma and acts as a promising indicator for prognosis and immunotherapy response
por: Liang, Xin, et al.
Publicado: (2022)

Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma
por: Wan, Qi, et al.
Publicado: (2020)

Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer
por: Deng, Yali, et al.
Publicado: (2021)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Uveal Melanoma
por: Pfeffer, Ulrich
Publicado: (2019)

Autophagy-Related Long Non-coding RNA Signature as Indicators for the Prognosis of Uveal Melanoma
por: Cui, Yi, et al.
Publicado: (2021)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patients
por: Grynberg, Shirly, et al.
Publicado: (2022)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

A Comparative Transcriptomic Analysis of Uveal Melanoma and Normal Uveal Melanocyte
por: An, Jianhong, et al.
Publicado: (2011)

Role of Epigenetics in Uveal Melanoma
por: Li, Yongyun, et al.
Publicado: (2017)

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
por: Bommareddy, Praveen K., et al.
Publicado: (2019)

MRI of Uveal Melanoma
por: Ferreira, Teresa A., et al.
Publicado: (2019)

The biology of uveal melanoma
por: Amaro, Adriana, et al.
Publicado: (2017)

Uveal Melanoma Metastasis
por: Rossi, Ernesto, et al.
Publicado: (2021)

Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma
por: Li, Yue, et al.
Publicado: (2023)

A Rare Thyroid Metastasis from Uveal Melanoma and Response to Immunotherapy Agents
por: Collins, Dearbhaile Catherine, et al.
Publicado: (2016)

EMT-Related Gene Signature Predicts the Prognosis in Uveal Melanoma Patients
por: Lv, Yufei, et al.
Publicado: (2022)

Identification of 5 microRNA biomarkers associated with the prognosis of uveal melanoma
por: Sun, Yabin, et al.
Publicado: (2022)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

Construction of an immunogenic cell death-based risk score prognosis model in breast cancer
por: Li, Yanling, et al.
Publicado: (2022)

Prognosis Prediction of Uveal Melanoma After Plaque Brachytherapy Based on Ultrasound With Machine Learning
por: Luo, Jingting, et al.
Publicado: (2022)

Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
por: Zhang, Jiulong, et al.
Publicado: (2022)

Cytokines concentrations in aqueous humor of eyes with uveal melanoma
por: Cheng, Yong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4b5281kbkv75uaqqbs82c3tn7u